PHVS
Pharvaris N.V.
NASDAQHealthcareBiotechnologyNL
Rating:C
Company Profile
CEO
Berndt Modig
IPO Date
2021-02-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
NL
Pharvaris N.V.
CEO
Berndt Modig
IPO Date
2021-02-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
NL
| $34.00 |
| 23 Jun 2026 | Lu Peng | Chief Medical Officer | M-Exempt | Disposed | 300 | $2.59 |
| 17 Jun 2026 | Modig Berndt | director, officer: Chief Executive Officer | S-Sale | Disposed | 2,191 | $31.05 |
| 17 Jun 2026 | Modig Berndt | director, officer: Chief Executive Officer | S-Sale | Disposed | 100 | $31.46 |
| 16 Jun 2026 | Lu Peng | Chief Medical Officer | F-InKind | Disposed | 117 | $32.20 |
| 15 Jun 2026 | Lu Peng | Chief Medical Officer | F-InKind | Disposed | 109 | $31.51 |
| 8 Jun 2026 | Nijdam Anna | Principal Accounting Officer | S-Sale | Disposed | 2,670 | $30.87 |
| 26 May 2026 | Monges Viviane | director | S-Sale | Disposed | 9,667 | $30.29 |
| 26 May 2026 | Nijdam Anna | Principal Accounting Officer | M-Exempt | Acquired | 1,829 | $20.00 |